Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Kivu Bioscience Inc.
Exscientia AI Limited
AstraZeneca
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
PMV Pharmaceuticals, Inc
Neonc Technologies, Inc.
Radiopharm Theranostics, Ltd
Tasca Therapeutics
MacroGenics
MacroGenics
SystImmune Inc.
SN BioScience